Let's Connect

News

Updates on CTx-1301, NDA Resubmission After FDA Complete Response Letter

By Industry News 1 min read

​Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests  — From Psychiatric Times articles Read More

Share this post
All News posts
News Industry News 11:00 am New National Guidance for Managing Medetomidine Intoxication and Withdrawal ​The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.  — From Psychiatric Times articles Read More News Industry News 10:00 am Can Digital Memory Tests Detect Tau-Related Cognitive Change Before Alzheimer Disease? ​Digital memory tests flag subtle preclinical Alzheimer changes, especially with neocortical tau; scalable tools may boost future trial screening.  — From Psychiatric Times articles Read More News Industry News 9:00 am Bridging the Rift: Tips to Improve the Emergency Medicine and Psychiatric Clinician Relationship ​How ED physicians and psychiatrists team up to cut mental health boarding, reduce unnecessary tests, and deliver faster, safer ED crisis care.  — From Psychiatric Times articles Read More

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.